Profile | GDS2987 / GI_31563349-A |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 11 | 37 |
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 9.3 | 31 |
GSM215254 | HMVEC_atorvastatin_rep1 | 20.6 | 47 |
GSM215282 | HMVEC_atorvastatin_rep3 | 7.4 | 18 |
GSM215344 | HMVEC_atorvastatin_rep2 | 19.7 | 44 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 11.3 | 22 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 2.3 | 5 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 40.6 | 55 |
GSM215294 | HMVEC_SLx2119_rep1 | 4.6 | 17 |
GSM215295 | HMVEC_SLx2119_rep2 | 57.7 | 68 |
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 15.9 | 25 |
GSM215298 | PASMC_vehicle_rep2 | 13.8 | 22 |
GSM215310 | PASMC_vehicle_rep3 | 35.1 | 49 |
GSM215311 | PASMC_atorvastatin_rep1 | 12 | 21 |
GSM215312 | PASMC_atorvastatin_rep2 | 4.7 | 8 |
GSM215313 | PASMC_atorvastatin_rep3 | 6.4 | 10 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 19.3 | 32 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 14.8 | 28 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 50.4 | 62 |
GSM215327 | PASMC_SLx2119_rep1 | 18.9 | 32 |
GSM215328 | PASMC_SLx2119_rep2 | 13.8 | 25 |
GSM215329 | PASMC_SLx2119_rep3 | 9.7 | 19 |
GSM215330 | Fibroblasts_vehicle_rep1 | 38.6 | 61 |
GSM215331 | Fibroblasts_vehicle_rep2 | 44.5 | 67 |
GSM215332 | Fibroblasts_vehicle_rep3 | 32.6 | 64 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 69.8 | 72 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 44.6 | 67 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 38.3 | 62 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 22.5 | 56 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 30.4 | 63 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 27.9 | 58 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 15.9 | 43 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 31.6 | 61 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 5.6 | 15 |